New research (nt. J. Mol. Sci. 2017) examined the impact of a prebiotic, based on Galacto-oligosaccharides (GalOS) with β-1,6 and β-1,3 linkages, on markers of colorectal cancer in Wister rats. The researchers also included an insulin control group and found that both prebiotic treatments decreased concentrations of harmful bacteria.


We drive enterprise value through organizational culture improvement. Go from surviving to thriving utilizing proven strategies surrounding trust and transparency.